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Highlights 
 
 This is the first review to identify and evaluate interventions aimed at 
increasing maternal influenza vacine uptake. 
 There is little high-quality evidence from randomized controlled trials to guide 
public health recommendations on improving maternal influenza vaccination 
rates.  
 Based on the existing evidence, clinicians should provide influenza education 
pamphlets to pregnant women accompanied by a verbalized statement on the 
benefits of maternal vaccination to newborns. 
 High-quality RCTs are needed to further evaluate interventions to successfully 
improve maternal influenza vaccination rates.  
 
 
Highlights (for review)
 
 
2 
ABSTRACT  18 
Background:  Pregnant women and their infants under 6 months of age infected with 19 
influenza have a high risk of serious morbidity and mortality. Influenza vaccine 20 
during pregnancy offers 3-for-1 benefits to pregnant women, fetuses and newborn 21 
infants. Current vaccination uptake rates during pregnancy, however, are often lower 22 
than other high-risk groups and the general population.  23 
Methods:  We systematically reviewed evidence on the effectiveness of interventions 24 
to improve influenza vaccination coverage in pregnant women. Risk differences 25 
(RDs) were calculated from the included studies.  26 
Results:  Eleven studies were included in the review, of which four were randomized 27 
controlled trials (RCTs). Three cohort studies assessed provider-focused interventions 28 
while four RCTs and one cohort study evaluated pregnant women-focused 29 
interventions. Two cohort studies and a prospective intervention study assessed the 30 
effectiveness of bundled interventions. No study solely assessed the effectiveness of 31 
interventions to enhance access to influenza vaccination. One moderate quality RCT 32 
showed that an influenza pamphlet, with or without a verbalized benefit statement, 33 
improved the vaccination rate (RD = 0.26; RD = 0.39). The other reviewed RCTs 34 
showed discordant results, with RDs ranging from -0.15 to 0.03. Although all 35 
observational studies significantly improved vaccination rates (RDs ranged from 0.03 36 
to 0.44), the quality of the evidence varied.  37 
Conclusions: There is a lack of effective interventions to increase the influenza 38 
vaccination rate in pregnant women. Based on the existing research, we recommend 39 
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that clinicians provide influenza pamphlets to pregnant women with a verbalized 40 
statement about the benefits of influenza vaccine to newborns. Further high-quality 41 
RCTs are needed to develop successful maternal influenza vaccination programs. 42 
Increased clarity in reporting the content of interventions would help to improve the 43 
comparability and generalizability of the published studies.  44 
45 
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1. Background 46 
Morbidity and mortality due to influenza infection is disproportionately higher in 47 
pregnant women and infants under six months old than in the general population (1-48 
5). Pregnant women infected with influenza are much more likely to experience 49 
serious illness, and the infection may have an adverse impact on fetal growth and 50 
development (6,7). In addition, when compared with other age groups, infants under 6 51 
months of age infected with influenza have higher rates of severe influenza-related 52 
complications, resulting in excess hospitalizations (8-14), prolonged stays in the 53 
intensive care unit (10), and higher mortality rates (15). 54 
Inactivated influenza vaccine is safe at any stage of pregnancy (16-20) and it provides 55 
substantial protection to pregnant women, unborn fetuses (21) and infants up to 6 56 
months old (17). Early infant protection is important since the current influenza 57 
vaccine is not licensed for this age group because of its low immunogenicity in 58 
newborns (22). In view of this triple protection provided by influenza vaccine, the 59 
World Health Organization (WHO) now recommends that pregnant women have the 60 
highest priority for vaccination in national seasonal influenza vaccination programs 61 
(2). However, seasonal influenza vaccination rates among pregnant women have not 62 
increased substantially (23-25) and are often much lower than national targets, other 63 
high-risk groups, and the general population (26-28). In an era of increasing threats 64 
from both seasonal and pandemic influenza, effective interventions that can enhance 65 
vaccination uptake among pregnant women need to be identified.  66 
Researchers have reviewed strategies to improve influenza vaccination in the general 67 
population (29,30), healthcare workers (31), those over 60 years of age (32-34), and 68 
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children (35,36). A recent review summarized the factors associated with vaccine 69 
uptake in pregnant women (37). Although some recent studies have evaluated the 70 
effectiveness of various interventions in improving maternal influenza immunization 71 
rates, to our knowledge no systematic review of these interventions has been 72 
conducted. Thus, we systematically reviewed the literature to identify and evaluate 73 
interventions used to improve immunization uptake among pregnant women. This 74 
review will present the best available evidence that can be used by public health 75 
policy makers and obstetric health care providers to develop effective vaccination 76 
programs that can increase influenza vaccine uptake in this high-risk group.   77 
 78 
2. Methods 79 
This systematic review was conducted in accordance with the Preferred Reporting 80 
Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (38). 81 
2.1. Search strategy  82 
We systematically searched electronic databases including PubMed, MEDLINE, 83 
EMBASE, CINAHL, and the Cochrane Central Register of Controlled Trials 84 
(CENTRAL) (The Cochrane Library, 2014, issue 8), containing the Cochrane Acute 85 
Respiratory Infections Group’s Specialized Register. Since annual influenza 86 
vaccination was first recommended in any trimester in the US in May 2004 (39), we 87 
included articles published from May 2004 to August 2014. The following search 88 
terms were used in all fields regardless of publication date and language:   89 
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#1:  vaccin*(truncation) OR immuni* 90 
#2:  influenza* OR flu 91 
#3:  preg* OR matern* 92 
To identify further studies of interest, we also performed a manual search of the 93 
reference lists of relevant publications.  94 
2.2. Eligibility criteria 95 
We included all original research articles that reported on interventions to increase 96 
influenza vaccine uptake during pregnancy. Studies comparing the immunization rate 97 
with either a historical control group during different observation seasons or a 98 
concurrent control group during the same observation season were considered. The 99 
study outcome measure assessed was the influenza vaccination rate, confirmed by 100 
either medical records or self-reported data. Study protocols and conference abstracts 101 
were excluded.  102 
2.3. Study selection 103 
Two reviewers (VW and KL) independently screened all study titles identified by the 104 
initial search and subsequently reviewed the abstracts of potentially relevant studies. 105 
If the studies described interventions to enhance maternal influenza vaccine uptake, 106 
the reviewers performed a full review. The reference lists of included studies were 107 
reviewed for additional studies that might have been missed in the initial search. The 108 
relevance and eligibility of each study was determined through consensus discussions 109 
between the two reviewers.  110 
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2.4. Data analysis 111 
Standardized study effects were reported as the ratio of the odds to be vaccinated in 112 
the intervention group compared with the standard care group and risk differences 113 
(RD) and 95% confidence intervals (CI) were calculated (40). Recalculated RDs prior 114 
to adjustment for confounders and 95% CIs were reported along with the results 115 
reported in the studies. And if available, a list of all confounders adjusted for in the 116 
data analysis and the differences in the vaccination rate after adjustment were 117 
described.  118 
To enhance the generalizability of our review results, we used the intervention 119 
classification guidelines from the Task Force on Community Preventive Services 120 
(41). They identified three types of interventions to enhance uptake of universally 121 
recommended vaccinations: (1) interventions to overcome provider and system 122 
barriers (i.e., physician-focused interventions), (2) interventions to increase demand 123 
for vaccination (i.e., pregnant woman-focused interventions), and (3) interventions to 124 
enhance vaccine access.  125 
Given the broad heterogeneity in study design and types of interventions, we did not 126 
conduct a quantitative pooled analysis.  127 
2.5. Evidence quality assessment 128 
Two reviewers (VW and KL) independently evaluated the methodological quality of 129 
the included studies. The Cochrane Collaboration method, a well-validated and 130 
reliable domain-based evaluation tool, was used for the risk of bias assessment of 131 
randomized controlled trials (42). The risk of bias was assessed in six domains: 132 
 
 
8 
sequence generation, allocation concealment, blinding, handling of incomplete 133 
outcome data, selective outcome reporting, and “other” potential threats to validity. A 134 
‘risk of bias summary’ showing the quality assessment of all included studies was 135 
generated using RevMan (43). For each outcome, the Grading of Recommendations 136 
Assessment, Development and Evaluation (GRADE) criteria were also used to assess 137 
the risk of bias (42). The GRADE criteria were adopted in addition to the Cochrane 138 
Collaboration tool because these criteria, take into account the consistency, directness, 139 
and precision of the results in addition to the risk of bias. The quality rating of 140 
randomized trials begins as high. The quality of evidence of each study is then 141 
downgraded to moderate, low or very low after considering the severity of the risk of 142 
bias, consistency, directness, and precision of the results.  143 
Since both the “risk of bias” tool and GRADE criteria were not developed with 144 
observational studies in mind, these studies were assessed separately using the 145 
Newcastle-Ottawa Scale (42). Studies were appraised across three categories: (1) 146 
selection of cohorts (4 criteria), (2) comparability of cohorts (1 question), and (3) 147 
ascertainment of the exposure of interest for cohort studies (3 questions). All criteria 148 
receive a maximum score of “one star” except for comparability of study groups 149 
where an additional star may be allocated for the control of confounding factors. The 150 
Coding Manual and Assessment Scale of Newcastle-Ottawa scale are described in the 151 
Supplementary File. 152 
 153 
3. Results 154 
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3.1. Search results 155 
The initial search yielded 2,941 published articles, from which 1,376 duplicate papers 156 
were removed (see Figure 1). After examining the titles and abstracts, irrelevant 157 
articles such as interventions with non-pregnant populations, studies with no 158 
intervention components, commentaries, and guidelines and recommendations, were 159 
removed. Finally, twenty-five of the remaining 1,565 articles were retrieved based on 160 
their title and abstract content. After full review, we excluded 14 papers because they 161 
included an ineligible population (n=5) or outcome (n=4), did not have a standard 162 
care group for comparison (n=4), or were a review article (n=1), (44-57) (see 163 
Supplementary File). No additional articles were identified from the reference lists of 164 
the relevant publications and 11 studies that met the selection criteria were reviewed.  165 
3.2. Study characteristics 166 
3.2.1. Study design  167 
The 11 included studies, which involved 16 intervention components, were all 168 
published between 2007 and 2014 (Table 1). Nine studies were conducted in the 169 
United States (US) (58-61,63,65-68), one in Canada (64) and one in Australia (62).  170 
3.2.2. Participants 171 
The sample sizes varied from 126 to 21,292 participants, with a mean of 2,531. 172 
Pregnant women were recruited from antenatal outpatient clinics, primary care 173 
outpatient clinics, tertiary hospitals and multispecialty medical organization. In all but 174 
one historical control study (64) a priori sample size calculations were performed. 175 
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Apart from two studies that recruited postnatal participants (62,68), all studies 176 
included only pregnant women who had antenatal medical appointments (58-61,63-177 
67). The characteristics of participants varied across the studies. They ranged from 14 178 
to 50 years old and were Hispanic, Caucasian, African-American, Asian or 179 
multiracial; four studies did not provide this information (63,64,66,67).  180 
3.2.3. Types of interventions  181 
All included studies involved at least one of the three previously identified 182 
intervention components with most studies (n=8) using only one component (58-183 
61,63-66). Three studies used provider-based interventions only (63,65,66), five 184 
studies used pregnant woman-focused interventions only (58-61,64), and three studies 185 
used a combination of the three types of intervention components (62,67,68) (Table 186 
2).  187 
3.2.4. Use of standard care group 188 
Standard care varied and included routine automated telephone appointment 189 
reminders (58), text messages about general preventive health in pregnancy (60), a 190 
standard vaccine information sheet (61) and routine antenatal care (58,59,61-68).  191 
3.2.5. Outcome measures 192 
Six studies ascertained the vaccination status through medical records from hospital 193 
databases (58,60,63,65-67), four studies used self-reported data (61,62,64,68), and 194 
one study used a combination of self-reported data and medical records (59).  195 
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3.3. Critical appraisal  196 
3.3.1. Risk of bias (internal validity) 197 
3.3.1.1. Randomized controlled trials 198 
The evidence quality of one RCT was  “high” (60), two were “moderate” (58,59) and 199 
one was “low” (61) (see Table 3). Random sequence generation was done in three of 200 
the four RCTs (58-60) and the other RCT did not report this information (61). 201 
Allocation concealment was judged as adequate in only one study (60) while others 202 
did not report this clearly (58,59,61). No RCTs blinded the participants due to the 203 
nature of the intervention, and only two RCTs blinded the outcome assessors to the 204 
treatment allocation (59,60). In three studies, the proportion of missing outcomes 205 
likely resulted in negligible bias of the effect estimates (58-60). In one RCT targeting 206 
minority women, however, less than one-half of the participants completed follow-up 207 
(61). Study protocols were only available for two (59,60) of the four RCTs (58-61). 208 
Both of these studies included all of the pre-specified primary outcomes (i.e., the 209 
vaccination rate among pregnant women). Volunteer bias may have been a risk in two 210 
included RCTs since only a subset of eligible participants had been recruited (59,61). 211 
One study reported a dropout rate of 54% at the 30-day postpartum follow-up (61). 212 
However, other than educational attainment there were no significant differences in 213 
the baseline characteristics of participants retained in the study and those lost to 214 
follow-up. A priori sample size calculation was performed in all RCTs. Meharry et al. 215 
(59), Moniz et al. (60) and Stockwell et al. (58) Three studies had a sufficient number 216 
of participants in both arms to achieve 80% power (58-60), while one study did not 217 
meet the required sample size (61). It should also be noted that although adequately 218 
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powered, two studies had a small number of participants, with less than 50 per group 219 
in one study (59) and around 100 per group in another (60). The risk of bias of all 220 
RCTs is summarized in Figure 2.  221 
3.3.1.2. Observational studies  222 
The quality assessment of the seven observational studies is described in Table 4. For 223 
all studies, exposure was ascertained from existing interventions implemented to 224 
improve influenza vaccination rate among pregnant women; outcome assessment was 225 
based on either a medical records or vaccination billing record an in-person interview 226 
by the research staff. The response rates of questionnaires in two studies were low 227 
(64,68). Only one study compared the confounders between the different participant 228 
groups (65). The overall quality scores for the observational studies ranged from 3 to 229 
7 out of a maximum of 9.  230 
Significant changes in the vaccination rate of study participants in some observational 231 
studies may have been affected by changes in national vaccination recommendations 232 
for pregnant women over the years of those studies (64-67). Although the Advisory 233 
Committee on Immunization Practices (ACIP) in the US officially recommended 234 
maternal influenza vaccine in 1997, the recommendation was originally for vaccine 235 
administration in the second and third trimester only. In 2004, this recommendation 236 
was modified to include vaccination in any trimester (39) and Canada (69) and 237 
Australia (70) issued similar recommendations in 2007 and 2008, respectively. In four 238 
studies, the standard care groups included pregnant women that were recruited prior 239 
to 2004 in the US and prior to 2007 in Canada and the intervention groups included 240 
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participants recruited after the change in the vaccination recommendations (64-67). 241 
Thus, in these studies, the groups observed over time may not be comparable. 242 
3.4 Effect of various interventions in increasing influenza vaccine uptake 243 
3.4.1. Provider-focused interventions 244 
Provider-focused interventions are those that aim to reduce missed opportunities for 245 
influenza vaccination among pregnant women. Common strategies include notifying 246 
providers about the influenza vaccination status of pregnant women, setting up 247 
standing orders authorizing nursing staff to administer the vaccine without a medical 248 
consultation, giving provider feedback by reporting the clinic’s or department’s 249 
influenza vaccination rate, and providing education to improve the knowledge and 250 
attitudes of healthcare staff toward influenza vaccination in pregnancy. All studies 251 
assessing the effect of provider-focused interventions on vaccination rates were cohort 252 
studies.   253 
Two studies involved delivering either electronic reminders (63) or manually 254 
attaching notifications to antenatal records (65). Both studies compared provider 255 
reminders and recall systems alone with historical controls and reported a significant 256 
increase in the influenza vaccination rate. The RD generated from Klatt et al. (63) was 257 
0.19 (95% CI 0.14 to 0.25) while that from Sherman et al. (65) was 0.37 (95% CI 0.32 258 
to 0.41). Mouzoon et al. (66) evaluated the combined effect of implementing standing 259 
orders, giving provider feedback, and provider education on vaccination rates over six 260 
influenza seasons from 2003–04 to 2008–09. The RD increased with each successive 261 
influenza season ranging from 0.19 (95% CI 0.17 to 0.20) to 0.44 (95% CI 0.42 to 262 
0.46).   263 
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3.4.2. Pregnant woman-focused interventions 264 
Interventions to increase demand for influenza vaccination aim to enhance the self-265 
initiation and motivation of pregnant women to seek out influenza vaccine. Education 266 
and promotion materials targeting pregnant women can be disseminated by mass 267 
media campaigns, via the Internet, through posters and leaflets, through lectures and 268 
workshops, and by personalized reminder and recall systems. Five (45%) studies (58-269 
61,64) assessed the effect of pregnant woman-focused interventions alone while two 270 
studies also included other intervention components (62,68). Four of the five studies 271 
assessing the sole effect of pregnant woman-focused interventions were RCTs (58-272 
61), and the other was a historical control study (64). 273 
Stockwell et al. (58) assessed the combined effect of providing reminders and 274 
education via mobile phone text messages to increase seasonal influenza vaccination 275 
uptake among urban, low-income pregnant women. Although, the complete case 276 
analysis showed an insignificant increase [RD = 0.03, 95% CI -0.03 to 0.08] in the 277 
vaccination rate, after adjustment for gestational age and the number of clinic visits, 278 
participants in the intervention group were 30% more likely to be vaccinated [AOR = 279 
1.30, 95% CI 1.003 to 1.69] and to be vaccinated early in the 3
rd
 trimester [AOR = 280 
1.88, 95% CI 1.12 to 3.15].   281 
Education has been shown to be effective in changing various health behaviors in 282 
pregnant women (71-73). Four studies assessed the effectiveness of influenza 283 
vaccination education. Frew et al. (61) found that neither gain- nor loss-framed 284 
messages increased the likelihood of vaccination in minority women [RD = -0.14, 285 
95% CI -0.33 to 0.06 and RD = -0.15, 95% CI -0.33 to 0.05, respectively]. Moniz et 286 
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al. (60) found that 12 weekly electronic text messages about the importance of 287 
influenza vaccination during pregnancy did not significantly increase influenza 288 
vaccine uptake [RD = 0.02, 95% CI -0.11 to 0.14]. Conversely, Meharry et al. (59) 289 
found a significant increase in vaccination uptake with an education pamphlet alone 290 
[RD = 0.26, 95% CI 0.07 to 0.45] and when combined with a verbalized benefit 291 
statement [RD = 0.39, 95% CI 0.21 to 0.57]. In the observational studies, Yudin et al. 292 
(64) also found that an education pamphlet significantly increased seasonal influenza 293 
vaccine uptake [RD = 0.38, 95% CI 0.25 to 0.50]. 294 
3.4.3. Interventions to enhance access to influenza vaccination 295 
Interventions to enhance access to the influenza vaccine aim to reduce barriers that 296 
pregnant women may encounter, such as the cost and availability of the vaccine. 297 
Interventions in this category include providing influenza vaccine for free or at a 298 
reduced cost to all pregnant women, extending vaccination services to more locations 299 
and/or with longer hours, and ensuring adequate stock of the vaccine. We found no 300 
studies that implemented interventions solely focused on enhancing access to the 301 
vaccine. Three of the reviewed studies included strategies to enhance vaccine access 302 
along with other components, such as pregnant woman-focused or provider-focused 303 
strategies (62,67,68). Two were cohort studies (62,67) and one was a prospective 304 
intervention study (68). These studies are discussed in the next section on bundled 305 
interventions. 306 
3.4.4. Bundled interventions 307 
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McCarthy et al. (62) found that implementing an education campaign that involved 308 
putting provider reminders in the antenatal progress notes, providing influenza 309 
vaccination education to health care providers, developing an information brochure on 310 
influenza immunization for pregnant clients, and increasing vaccine stocks 311 
significantly increased the influenza vaccination rate among pregnant women [RD = 312 
0.10, 95% CI 0.01 to 0.19]. Similarly, Panda et al. (68) found that implementing a 313 
vaccine promotion intervention that included education and reminders to both 314 
providers and pregnant women and the provision of vaccine at antenatal clinics 315 
significantly increased influenza vaccine uptake [RD = 0.12, 95% CI 0.07 to 0.17]. 316 
Ogburn et al. (67) evaluated two combined interventions over two consecutive 317 
influenza seasons. In 2003-04, they provided education to providers and extended 318 
locations for vaccination service and in 2004-05, standing vaccination orders were 319 
added. The increase in vaccination after the 2003-04 influenza season was minimal 320 
[RD = 0.03, 95% CI 0.00 to 0.05] but after standing orders were implemented, the 321 
vaccination rate increased substantially [RD = 0.36, 95% CI 0.30 to 0.43].  322 
 323 
4. Discussion 324 
4.1. Summary of evidence 325 
Our analysis reveals that there are only 11 studies assessing the effectiveness of 326 
interventions that promote influenza vaccination in pregnant women. Only one 327 
moderate quality RCT showed that providing an education pamphlet, with or without 328 
a verbalized benefit statement, improved the influenza vaccination rate among 329 
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pregnant women. Three other RCTs did not significantly improve vaccination rates in 330 
the intervention groups. All of the observational studies did show significant increases 331 
in influenza vaccination rates, but the quality of evidence varied.  332 
Researchers in five studies reported a statistically significant difference in the 333 
vaccination rate of more than 0.20 (59,64-67), three studies showed a statistically 334 
significant difference of 0.10 to 0.19 (62,63,68), and three RCTs had no significant 335 
effect of the interventions (58,60,61). In general, higher quality studies showed a 336 
decrease in statistical significance and effect size. The overall quality and amount of 337 
evidence for the effectiveness of strategies to increase influenza vaccination uptake 338 
among pregnant women varied and the risks of bias in the observational studies is 339 
substantial. RCTs typically provide the best evidence for the efficacy of interventions. 340 
Unfortunately, the interventions in three of the four RCTs included in this review 341 
failed to increase the vaccination rate, even though two were adequately powered (58-342 
60). 343 
The quality of evidence was low among observational studies. Three cohort studies 344 
that showed a positive effect of provider-focused interventions (63,65,66) had 345 
relatively high quality scores. In particular, interventions involving provider 346 
reminders and/or recall only were associated with an increase in maternal vaccination 347 
uptake (63,65). Although the evidence should be interpreted with caution given the 348 
risk of bias, studies promoting vaccination in other target groups support this finding 349 
(71-73). In addition, an extensive systematic review found that provider reminders and 350 
recall systems are effective in increasing childhood vaccinations, influenza 351 
vaccinations among children and adults, and adult hepatitis B, pneumococcus, and 352 
tetanus vaccine uptake (30). Provider attitudes and practices matter because studies 353 
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show that HCPs have a substantial influence on decisions about influenza vaccination 354 
by pregnant women (28,37,74,75). However, at present there is insufficient high-355 
quality evidence from more rigorous study designs to draw firm conclusions about the 356 
effects of provider-focused interventions.  357 
The quality of evidence in studies assessing the effect of pregnant woman-focused 358 
interventions varied from very low to high with inconsistent results among the 359 
reviewed RCTs (58-61). A cohort study with a low-quality score also supports the 360 
effectiveness of pregnant woman-focused interventions. Although interventions such 361 
as text messages were well received by pregnant women, they failed to increase the 362 
actual vaccination rate (60). Using text messages to provide education and reminders 363 
has been shown effective in promoting human papillomavirus vaccination among 364 
children (76), hepatitis vaccination among travelers (77) and influenza vaccination in 365 
children (78). However, further studies are required to determine their effect on 366 
pregnant women. Moniz et al. (60) suggested that the content of the message might 367 
influence its effectiveness. Individualized messages using direct quotes from HCPs 368 
who unequivocally state the importance of maternal influenza vaccination and address 369 
vaccine barriers can be further investigated (60). Given the inconsistency of study 370 
findings and the low quality of evidence, we were unable to assess the specific effects 371 
of providing influenza-related education and/or advice to pregnant women. Therefore, 372 
more high-quality RCTs are necessary to assess the impact of interventions that 373 
directly target pregnant women. 374 
The studies in this review primarily focused on interventions targeting either 375 
providers or pregnant women. Interventions aimed at increasing access to influenza 376 
vaccination, such as on-site influenza vaccines for free or at a reduced cost, were not 377 
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found. With respect to increasing access to the vaccine, the reviewed studies included 378 
only three intervention components as part of bundled interventions: increasing 379 
vaccine stocks (62), increasing the number of locations to get the vaccine (67,68), and 380 
implementing standing orders for vaccination (67). Although the provision of free 381 
influenza vaccine has been an effective strategy to improve vaccination coverage in 382 
other high-risk groups and the general population (79-81), no study has assessed its 383 
effectiveness in pregnant women, who have different knowledge of and attitudes 384 
toward vaccination (37).  385 
Three studies, all with low to medium quality scores, evaluated the effectiveness of 386 
bundled interventions (62,67,68). All comprehensive bundled interventions 387 
demonstrated statistically significant increases in vaccination rates in pregnancy. 388 
However, unlike findings from studies in other populations (31,34), the magnitude of 389 
increase from bundled interventions was not higher than that from single component 390 
interventions.  391 
Higher quality and more methodologically rigorous studies were less likely to show 392 
significant improvements in influenza vaccine uptake when compared with studies of 393 
lower quality. While most of the reviewed studies were conducted over a single 394 
influenza season, Mouzoon et al. (66) demonstrated that sustained efforts over time 395 
could lead to increasingly higher vaccination uptake rates. Thus, the sustained impact 396 
of influenza vaccine promotion interventions should be explored in future studies.  397 
The effectiveness of influenza vaccination programs depends on their content. 398 
However a clear description of the content of many interventions, such as the wording 399 
used in pamphlets and the timing of the intervention, was not included in most study 400 
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reports. Increased clarity in reporting what specific provider and pregnant woman-401 
focused interventions were assessed and when they were implemented would help 402 
both researchers and practitioners to understand whether the effectiveness of a given 403 
strategy differs according to the specific content of the intervention. The reviewed 404 
studies provide some evidence that targeted interventions can improve influenza 405 
vaccine uptake among pregnant women across a wide range of settings, gestational 406 
ages, and socio-demographic backgrounds. The review findings are relevant to 407 
different end users, including HCPs and public health administrators, to guide the 408 
formulation of maternal vaccination programs. However, given the heterogeneity of 409 
the included studies, the broad range of intervention strategies and the limitations of 410 
the resulting evidence, there is insufficient evidence to give definitive 411 
recommendations for practice. 412 
4.2. Strengths and limitations 413 
Although the majority of studies reported significant increases in influenza vaccine 414 
uptake in pregnant women after the interventions, we did identify some limitations in 415 
the reviewed studies. First, the majority of included studies were non-randomized 416 
interventions. Most were adequately powered but susceptible to bias and thus provide 417 
only indirect evidence of effectiveness. One of the included RCTs did not achieve an 418 
adequate number of participants needed to achieve 80% power. As previously noted, 419 
changes in national vaccination policies for pregnant women cast doubt on the 420 
similarity of the standard care and intervention groups in some observational studies, 421 
a criterion that is not included in the Newcastle-Ottawa scale. Moreover, it was not 422 
possible to perform a meta-analysis because of the heterogeneity of the interventions 423 
and study methods. Also, most of the reviewed studies were done in the US, and the 424 
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findings may not be generalizable to other populations. Although our review 425 
attempted to standardize intervention into distinct components to increase their 426 
comparability (i.e., provider-focused, pregnant-women focused, or bundled), some 427 
studies included more than one component, which complicated comparisons between 428 
interventions. Furthermore, there were different implementation strategies for similar 429 
intervention components in different settings. For example, provider- and/or pregnant 430 
woman-focused reminders may use different wording in different studies. Lastly, 431 
publication bias may also be a concern in our review. Studies not demonstrating an 432 
increase in vaccination uptake may be less likely to be published. We assessed the 433 
publication bias graphically using a Begg’s funnel plot (82). However, since there 434 
were only 11 included studies, the power of the test for funnel plot asymmetry was 435 
too low to distinguish chance from real asymmetry.  Nevertheless, we systematically 436 
searched the WHO clinical trial portal (www.who.int/trialsearch), which contains the 437 
registration data from trial registries around the world, with the same search terms we 438 
used for this review. In addition to our included studies, we found only one registered 439 
pilot study to assess the effectiveness of text message reminders on maternal influenza 440 
vaccination uptake (#ACTRN12613000553774). No other registered studies were 441 
found. 442 
 443 
5. Conclusions  444 
Influenza vaccine in pregnancy is effective against influenza infection and lowers the 445 
risk of influenza-related complications and mortality in both pregnant women and 446 
their newborns. This review highlights the need for well-designed trials of various 447 
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single-component or bundled interventions that can be incorporated into a 448 
comprehensive antenatal vaccination programs. In the meantime, the best available 449 
evidence suggests that to increase vaccination rates, HCPs should inform all pregnant 450 
women about the benefits of vaccination, provide positive vaccination 451 
recommendations, use some type of reminder system to target unvaccinated pregnant 452 
women, and make influenza vaccine easily accessible. Given the well-documented 453 
benefits of influenza vaccine for pregnant women, establishing cost-effective 454 
interventions to increase vaccine uptake should be a public health priority.  455 
456 
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Table 1  
Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
A. Provider-focused intervention 
Klatt (63) Historical control study 
 
Standard care: 2007–2008 
influenza season; 
intervention: 2008-2009 
influenza season 
 
Standard care: routine 
antenatal care; 
intervention: routine 
antenatal care and a 
provider electronic 
reminder  
 
Pregnant women in 
an antenatal 
outpatient clinic  
 
USA 
 
N = 1280; standard 
care (2007) n = 638; 
intervention (2008) n 
= 645 
 
Intervention: 
393/ 645 
(60.9%) 
 
Standard care: 
267/ 639 
(41.8%) 
0.19  
[0.14, 0.25] 
After implementing the 
intervention, the 2008–
2009 influenza 
vaccination rate was 
significantly higher than 
that in 2007–2008 (p < 
.001, 95% CI for 
difference in proportions 
0.14 to 0.25). 
 
None. Not provided. 
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Table 1  
Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
Mouzoon 
(66) 
Retrospective cohort study 
 
Standard care: vaccination 
rates in 1998–2002; 
intervention: vaccination 
rates during influenza 
seasons 2003-2004 to 
2008-2009 
 
Standard care: routine 
antenatal care; 
intervention: routine 
antenatal care and 
provider-focused 
interventions including 
provider education, 
standing orders, and 
provider feedback  
Pregnant women in a 
multispecialty 
medical organization 
 
USA 
 
N = 21292; standard 
care (1998-2003) n = 
8813 
intervention 1 (2003-
04) n = 2231; 
intervention 2 (2004-
05) n = 2035; 
intervention 3 (2005-
06) n = 2040; 
intervention 4 (2006-
07) n = 2111; 
intervention 5 (2007-
08) n = 2039; 
intervention 6 (2008-
09) n = 2023 
 
Interventions: 
2003-04 
427/ 2023 
(21.1%) 
 
2004-05 
579/ 1893 
(30.6%) 
 
2005-06 
633/ 1945 
(32.5%) 
 
2006-07 
603/ 1488 
(40.5%) 
 
2007-08 
949/ 2039 
(46.5%) 
 
2008-09* 
760/ 2032 
(37.4%) 
 
Standard care: 
1998-2002 
222/ 8813 
(2.5%) 
 
2003-04 
0.19 [0.17, 
0.20] 
 
2004-05 
0.28 [0.26, 
0.30] 
 
2005-06 
0.30 [0.28, 
0.30] 
 
2006-07 
0.38 [0.35, 
0.41] 
 
2007-08 
0.44 [0.42, 
0.46] 
 
2008-09* 
0.35  
[0.33, 0.37] 
Influenza vaccination 
coverage rates among 
pregnant women 
increased from 2.5% at 
baseline to 21.1% in 
2003-2004, 30.6% in 
2004-2005, 32.5% in 
2005-2006, 40.5% in 
2006-2007, and 46.5% in 
2007-2008 and decreased 
to 37.4% in 2008- 2009. 
The lower rate in 2008-
2009 was attributed to 
clinic closure because of 
Hurricane Ike. 
Immunization occurred 
throughout pregnancy 
but was more likely to 
occur in second or third 
trimester.  
None. Not provided 
Table 1  
Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
Sherman 
(65) 
Retrospective cohort study 
 
Standard care: 2003; 
intervention: 2005 
 
Standard care: routine 
antenatal care; 
intervention: routine 
antenatal care and a 
provider-focused reminder  
 
Pregnant women in a 
primary care 
outpatient clinic 
 
USA 
 
N = 1367; standard 
care (2003) n = 504; 
intervention (2005) n 
= 863 
Intervention: 
445/ 863  
(51.6%) 
 
Standard care: 
74/ 504  
(14.7%) 
0.37  
[0.32, 0.41] 
An absolute increase of 
37% in vaccination rate 
before and after 
implementing 
intervention (RR = 3.51, 
p < 0.0001) 
None; study 
reports no 
significant 
difference in 
age, ethnicity, 
language, 
insurance 
status, 
education 
attainment, or 
presence of 
chronic illness 
between 
groups.  
 
Not provided. 
B. Pregnant woman-focused interventions 
Table 1  
Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
Frew
1 
(61) RCT 
 
Recruitment: Sep 2011 - 
May 2012; intervention: 
follow-up: Oct 2011 - May 
2013 
 
Standard care: standard 
vaccine information sheet; 
intervention 1: gain-
framed messages targeting 
pregnant women to 
articulate maternal 
vaccination benefits; 
intervention 2: loss-framed 
messages targeting 
pregnant women to 
illustrate negative 
consequences of foregoing 
vaccination  
 
Pregnant women in 
various venues (not 
specified) 
 
USA 
 
N = 126; standard 
care n = 39; 
intervention1 n = 45; 
intervention 2 n = 42 
Intervention 1 
11/45 
3
 
(24.4%) 
 
Intervention 2 
10/42 
3
 
(23.8%) 
 
Standard care:  
15/39 
3 
(38.5%) 
Intervention 1 
-0.14 
[-0.33, 0.06] 
 
Intervention 2 
-0.15 
[-0.35, 0.05] 
 
Both gain- (OR = 
0.5176; 95% CI = 0.203, 
1.322) and loss-framed 
messages (OR = 0.5000; 
95% CI 0.192 to 1.304) 
had insignificant 
associations with 
increased likelihood of 
immunization during 
pregnancy.  
 
None; study 
reports no 
significant 
differences in 
age, 
educational 
attainment, 
ethnicity, 
employment 
status, income, 
or marital 
status at 
baseline 
among groups.  
Not provided. 
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Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
Meharry
2
 
(59) 
RCT 
 
Recruitment: 22 Sep 2011 
– 2 Feb 2012; follow-up: 
Apr 2012 
 
Standard care: routine 
antenatal care; intervention 
1: influenza education 
pamphlet; intervention 2: 
influenza education 
pamphlet and a verbalized 
benefit statement: 
“vaccinating the pregnant 
woman also benefits the 
young infant” 
 
Pregnant women in 3 
antenatal outpatient 
clinics 
 
USA 
 
N = 133; standard 
care n = 49; 
intervention 1 n = 48; 
intervention 2 n = 36 
 
Intervention 1 
35/48  
(72.9%)  
 
Intervention 2 
31/36  
(86.1%) 
 
Standard care: 
23/49  
(46.9%) 
Intervention 1 
0.26  
[0.07, 0.45] 
 
Intervention 2 
0.39  
[0.21, 0.57] 
Both intervention groups 
had higher vaccination 
rates than standard care 
group (2 = 13.74, df = 1, 
p < 0.001) 
 
The difference between 
the two treatment groups 
was not statistically 
significant (2  = 2.127, df 
= 1, p = 0.145) 
 
None; study 
reports no 
significant 
differences in 
age, parity, 
trimester, 
ethnicity, 
marital status, 
employment 
status, 
education 
attainment, 
income, 
prenatal site, 
ever had 
influenza or 
ever had flu 
vaccine at 
baseline 
among groups. 
 
Not provided. 
Table 1  
Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
Moniz 
(60) 
 
 
 
 
 
RCT 
 
Recruitment: 2 influenza 
seasons Sep 2010 – Feb 
2012; follow-up: 12 weeks 
after enrollment 
 
Standard care: routine 
antenatal care and 12 
weekly text messages 
about general preventive 
health in pregnancy; 
intervention: standard care, 
12 weekly text messages 
about general preventive 
health in pregnancy and 
the importance of 
influenza vaccination in 
pregnancy 
 
Pregnant women in 
an antenatal 
outpatient clinic 
 
USA 
 
N = 204; standard 
care n = 100; 
intervention n = 104 
Intervention: 
34/104  
(32.7%) 
 
Standard care: 
31/100 
(31.0%) 
0.02  
[-0.11, 0.14] 
There was no difference 
in influenza vaccination 
rate between standard 
care and intervention 
groups (difference = 
1.7%, 95% CI  -11.1% to 
14.5%) 
None; study 
reports no 
significant 
difference in 
age, ethnicity, 
education 
attainment, 
marital status, 
income, or 
insurance at 
baseline 
between 
groups.  
Not provided. 
Table 1  
Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
Stockwell 
(58) 
RCT 
 
Recruitment: 1 Feb 2011 – 
15 Aug 2011; 19 Sep 2011 
– 31 Dec 2011 
 
Standard care: routine 
automated telephone 
appointment reminders; 
intervention: standard care 
plus text messages 
involving pregnant 
woman-focused education 
and reminders  
Pregnant women in 5 
primary care 
outpatient clinics 
 
USA 
 
N = 1153; standard 
care n = 577; 
intervention n = 576 
Intervention:  
284/576 
(49.3%) 
 
Standard care: 
269/577 
(46.6%) 
0.03 
[-0.03, 0.08] 
The cumulative 
vaccination rates were 
49.3% in the intervention 
group versus 46.6% in 
the standard care group 
(relative rate [RR] = 
1.06; 95%CI = 0.94, 
1.19; difference = 2.7%; 
95% CI = –3.2%, 8.6%). 
After adjusting for 
gestational age and 
number of clinic visits, 
women who received 
intervention were more 
likely to receive an 
influenza vaccination 
(adjusted odds ratio 
[AOR] = 1.30; 95% CI = 
1.003, 1.69). 
 
The greatest effect was 
observed among women 
in third trimester when 
intervention was 
implemented (AOR = 
1.88, 95% CI 1.12 to 
3.15) 
 
Gestational 
age and 
number of 
clinic visits 
After adjusting for 
confounders, women 
who received the 
intervention rose 
from 6% to 30% 
more likely to be 
vaccinated (adjusted 
odds ratio [AOR] = 
1.30; 95% confidence 
interval [CI] = 1.003, 
1.69).  
Table 1  
Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
Yudin (64) Historical control study 
 
Standard care: fall 2006; 
intervention: fall 2007 
 
Standard care: routine 
antenatal care; 
intervention: routine 
antenatal care and a 
pregnant woman-focused 
education pamphlet  
 
Postpartum women in 
an antenatal 
outpatient clinic 
 
Canada 
 
N = 240; standard 
care (2006) n = 58; 
intervention (2007) n 
= 182 
 
Intervention: 
103/ 182 
(56.6%) 
 
Standard care:  
11/ 58  
(19.0%) 
0.38  
[0.25, 0.50] 
56% of women reported 
receiving influenza 
vaccine during current 
pregnancy, significantly 
higher than the 19% of 
women who reported 
receiving vaccine in the 
sample in 2006 (p < 
0.001) 
None. Not provided. 
C. Interventions with bundled components 
Table 1  
Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
McCarthy 
(62) 
Historical control study 
 
Standard care: 2 
consecutive weeks in Jul 
2010; intervention: 2 
consecutive weeks in Jul 
2011 
 
Standard care: routine 
antenatal care; 
intervention: routine 
antenatal care and  
a multicomponent 
education campaign 
involving provider 
education, provider 
reminders, pregnant 
woman-focused education 
and increased vaccine 
access 
 
Postpartum women in 
a tertiary hospital 
 
Australia 
 
N = 439; standard 
care (2010) n = 199; 
intervention (2011) n 
= 240 
Intervention: 
96/ 240 
(40.0%) 
 
Standard care: 
60/ 199  
(30.2%) 
0.10  
[0.01, 0.19] 
Influenza vaccine 
coverage increased from 
30% in 2010 audit to 
40% in 2011 (p = 0.03) 
None.  Not provided. 
Table 1  
Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
Ogburn 
(67) 
Retrospective cohort study  
 
Standard care: 1 Oct 2002 
– 31 Mar 2003; 
intervention 1: 1 Oct 2003 
– 31 Mar 2004; 
intervention 2: 1 Oct 2004 
– 31 Mar 2005 
 
Standard care: routine 
antenatal care; intervention 
1 (2003-04): routine 
antenatal care, provider-
focused education, 
increase availability of 
vaccine in clinic, and a 
screening protocol for 
nurses; intervention 2 
(2004-05): intervention 1 
plus standing orders 
allowing nurses to 
administer vaccine without 
involvement of provider 
 
Pregnant women in 
an antenatal 
outpatient clinic 
 
USA 
 
N = 602 
Standard care (2002-
03) n = 190 
Intervention 1 (2003-
04) n = 220 
Intervention 2 (2004-
05) n = 192 
Intervention: 
2003-04 
7/220 
4
 
(3.2%) 
 
2004-05 
71/192 
4
 
(37.0%) 
 
Standard care:  
2002-03 
1/190 
4
 
(0.5%) 
2003-04 
0.03  
[0.00, 0.05] 
 
2004-05 
0.36  
[0.30, 0.43] 
The overall vaccination 
rate was 0.5% in 2002-
03, 3% in 2003-04 (p = 
0.07), and 37% in 2004-
05 (p < 0.001) 
None; study 
reports no 
significant 
difference in 
age, gravidity, 
gestational 
age, prenatal 
care clinic 
type among 
groups. 
Not provided. 
Table 1  
Characteristics of included studies 
Author 
Study design, period and 
methods  
Participants, setting 
and sample size 
Reported 
vaccine 
coverage rates 
Computed RD  
(95% CI) Authors reported results 
Confounders 
adjusted for 
Difference in 
vaccination rate after 
adjustment 
Panda (68) Prospective interventional 
study 
 
Standard care: influenza 
season 2007–2008; 
intervention: 2008-2009 
 
Standard care: routine 
antenatal care; 
intervention: routine 
antenatal care and a 
multicomponent education 
program which involved 
provider-focused 
education and reminders, 
pregnant woman- focused 
education and reminders 
and provision of vaccine at 
antenatal clinics 
 
Postpartum women in 
a tertiary hospital  
 
USA 
 
N = 1000; standard 
care (2007-08) n = 
520; intervention 
(2008-09) n = 480 
Intervention: 
149/ 480 
(31.0%) 
 
Standard care: 
99/ 520  
(19.0%) 
0.12  
[0.07, 0.17] 
Influenza vaccination 
rates increased from 19% 
to 31% after 
intervention. Pregnant 
women with 
comorbidities were more 
likely to be vaccinated 
than healthy pregnant 
women.  
None.  Not provided. 
1
 Although the study appears to meet the criteria for a randomized controlled trial, no study design is specified and no trial registry is available 
2 
No trial registry is available 
3
 The number of vaccinated participants was estimated based on the odds ratios provided by the authors 
4 
The number of vaccinated participants was estimated based on the percentages provided by the authors 
Table 2  
Strategies used to improve influenza vaccination uptake among pregnant women 
  
Interventions to overcome provider/ system barriers 
(Physician-focused intervention)  
Interventions to increase 
demand (Pregnant woman-
focused intervention)  
Interventions to enhance 
vaccination access 
Study   
Provider 
reminder/ recall 
Standing 
orders 
Provider 
feedback 
Provider 
education  
Pregnant 
woman 
reminder/ recall 
Pregnant 
woman 
education  
Extend service 
location 
Increase 
stock 
Frew (61)        √    
Klatt (63)  √          
McCarthy (62)  √   √   √   √ 
Meharry (59)        √    
Moniz (60)        √    
Mouzoon (66)   √ √ √       
Ogburn (67)    √  √     √  
Panda (68)  √   √   √  √  
Sherman (65)  √          
Stockwell (58)       √ √    
Yudin (64)        √    
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Table 3 
Quality assessment of the reviewed randomized controlled trials using the GRADE criteria 
 Risk of Bias     
Study 
Random 
sequence 
generation  
Allocation 
concealment 
Blinding of 
participants & 
outcome 
assessment  
Incomplete 
outcome data 
Selective 
reporting Other bias Inconsistency Indirectness Imprecision 
Quality of  
evidence 
Frew (61) No information 
provided, 
unclear 
No information 
provided, 
unclear 
Participants: No 
Assessors: 
Unclear 
Quote: "… 
resulting in our 
final retention 
of 46% of the 
recruited study 
population". 
 
Comments: The 
proportion of 
missing 
outcomes 
compared with 
observed event 
risk was high 
enough to 
induce clinically 
relevant bias in 
intervention 
effect estimates. 
Per-protocol 
analysis was 
done.  
 
Quote: “Using 
seasonal 
influenza 
immunization as 
our primary 
outcome 
variable”. 
 
Comments: The 
study protocol is 
not available but 
the study likely 
included all pre-
specified 
primary 
outcomes. 
Quote: "... the 
potential for 
participatory 
bias as women 
who were 
agreeable to 
participating in 
the study were 
included and 
therefore may 
not be 
representative of 
the actual 
population …". 
 
Comments: The 
study may be 
affected by 
volunteer bias. 
 
No serious 
inconsistency 
(only one RCT 
included) 
No serious 
indirectness 
Insufficient 
number of 
participants in 
both arms (80% 
power) 
 
LOW 
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Table 3 
Quality assessment of the reviewed randomized controlled trials using the GRADE criteria 
 Risk of Bias     
Study 
Random 
sequence 
generation  
Allocation 
concealment 
Blinding of 
participants & 
outcome 
assessment  
Incomplete 
outcome data 
Selective 
reporting Other bias Inconsistency Indirectness Imprecision 
Quality of  
evidence 
Meharry (59) Quote: 
“Pregnant 
women were 
randomly 
assigned to one 
of the three 
groups, based 
upon the 
chronological 
entry into the 
study and the 
Web-based 
random number 
generator”. 
 
Comments: 
Done. 
 
Quote: “The 
study number 
was paired with 
a predetermined 
random-
assigned 
intervention”. 
 
Comments: 
Likely not done. 
Participants: No 
Assessor: Yes 
 
Quote: “Proof of 
vaccination was 
obtained by the 
clinic RN or 
prenatal 
instructor 
outside the 
research team 
and therefore 
unaware of the 
random 
assignment”. 
Quote: “Two 
women 
transferred out 
of the system 
and were lost to 
follow up …”, 
 
Comments: The 
proportion of 
missing 
outcomes 
compared with 
observed event 
risk was not 
enough to 
induce clinically 
relevant bias in 
intervention 
effect estimates. 
Per-protocol 
analysis was 
done.  
 
Quote: “The 
primary 
outcome 
measure was 
influenza 
vaccine uptake 
(vaccination)”. 
 
Comments: The 
study protocol is 
not available but 
the study likely 
included all pre-
specified 
primary 
outcomes. 
Quote: 
“Potential 
participants in 
the prenatal 
clinics were 
approached by 
the principal 
investigator in 
the waiting 
rooms (site 1 
and 2) or by one 
of three 
registered nurses 
(RNs) in the 
patient work- up 
room (site 3), 
prior to their 
appointment”. 
 
Comments: The 
study may be 
affected by 
volunteer bias. 
 
No serious 
inconsistency. 
No serious 
indirectness. 
Sufficient 
number of 
participants in 
both arms (80% 
power). 
MODERATE 
Table 3 
Quality assessment of the reviewed randomized controlled trials using the GRADE criteria 
 Risk of Bias     
Study 
Random 
sequence 
generation  
Allocation 
concealment 
Blinding of 
participants & 
outcome 
assessment  
Incomplete 
outcome data 
Selective 
reporting Other bias Inconsistency Indirectness Imprecision 
Quality of  
evidence 
Moniz (60) Quote: 
“Participants 
were 
randomized to 
the two study 
arms with equal 
frequency using 
a permuted 
block design 
with random 
block sizes of 
two, four, and 
six”. 
 
Comments: 
Done. 
Quote: “The 
randomization 
sequence was 
generated and 
group 
assignments 
were placed in 
sequentially 
numbered, 
sealed, opaque 
envelopes by a 
researcher (L.A. 
M.) uninvolved 
in participant 
recruitment or 
clinical care”. 
 
Comments: 
Done. 
 
Participants: No 
Assessors: Yes 
 
Quote: “Health 
care providers 
were blind to the 
groups to which 
participants 
were 
randomized”. 
 
Quote: “The 
final intention-
to-treat analysis 
included 204 
participants ... 
For the per-
protocol 
analysis, 18 
patients in the 
General group 
and 28 patients 
in the Flu group 
were deemed 
nonevaluable … 
or they were lost 
to follow-up”. 
 
Comments: The 
proportion of 
missing 
outcomes 
compared with 
observed event 
risk was not 
enough to 
induce clinically 
relevant bias in 
intervention 
effect estimates. 
Both intention-
to-treat and per-
protocol 
analyses were 
done.  
 
Quote: “The 
prespecified 
primary 
outcome was 
uptake of the 
influenza 
vaccine”. 
 
Comments: The 
study protocol is 
not available but 
the study 
probably 
included all pre-
specified 
primary 
outcomes. 
Quote: 
“Approximately 
2,100 obstetric 
patients received 
care in the 
Magee 
Outpatient 
Clinic during the 
study’s 
enrollment 
periods. Of 
these, 216 were 
enrolled in the 
study”.  
 
Comments: 
There may be a 
risk of volunteer 
bias but 
insufficient 
information was 
provided.  
No serious 
inconsistency. 
No serious 
indirectness. 
Sufficient 
number of 
participants in 
both arms (80% 
power). 
HIGH 
Table 3 
Quality assessment of the reviewed randomized controlled trials using the GRADE criteria 
 Risk of Bias     
Study 
Random 
sequence 
generation  
Allocation 
concealment 
Blinding of 
participants & 
outcome 
assessment  
Incomplete 
outcome data 
Selective 
reporting Other bias Inconsistency Indirectness Imprecision 
Quality of  
evidence 
Stockwell (58) Quote: “Eligible 
women were 
individually 
randomized to 
the text 
messaging 
intervention or 
to usual care 
using 1:1 
allocation 
stratified by 
clinic site, using 
the random 
sample 
algorithm … 
with a randomly 
generated start 
point”. 
 
Comments: 
Done. 
Comments: 
Insufficient 
information 
about the 
sequence 
generation 
process to 
permit 
judgment, 
unclear. 
Participants: No 
Assessors: 
Unclear 
Quote: “Five 
women at less 
than 14 weeks 
gestational age 
were removed 
from further 
analysis, as 
were 28 women 
who were 
vaccinated after 
randomization 
but before the 
intervention, 
and 1 duplicate 
patient. The 
remaining 1153 
women 
constituted the 
analytical group 
…”. 
 
Comments: The 
proportion of 
missing 
outcomes 
compared with 
observed event 
risk was not 
enough to 
induce clinically 
relevant bias in 
intervention 
effect estimates. 
Per-protocol 
analysis was 
done.  
 
Quote: “We 
evaluated the 
impact of 
influenza 
vaccine text 
message 
reminders in a 
low-income 
obstetric 
population”.  
 
Comments: The 
study protocol is 
not available but 
the study likely 
included all pre-
specified 
primary 
outcomes.  
The study 
appears to be 
free of other 
sources of bias. 
No serious 
inconsistency.  
No serious 
indirectness. 
Sufficient 
number of 
participants in 
both arms (80% 
power). 
MODERATE 
 
Table 4  
Quality assessment of the reviewed observational studies using the Newcastle-Ottawa scale for cohort studies 
a 
 
Quality assessment criteria Klatt (63) McCarthy (62) Mouzoon  (66) Ogburn (67) Sherman (65) Panda (68) Yudin (64) 
(1) Selection        
 Representativeness of exposed cohort * * * * * * * 
 Selection of non-exposed cohort -- -- -- -- -- -- -- 
 Ascertainment of exposure * * * * * * * 
 Demonstration that outcome of interest 
was not present at start of study 
-- -- -- -- -- -- -- 
(2) Comparability
a
        
 Comparability of cohorts on the basis of 
design and analysis 
-- -- -- -- * -- -- 
 Comparability of cohorts on the basis of 
design and analysis 
-- -- -- -- * -- -- 
(3) Outcome        
 Assessment of outcome * -- * * * -- -- 
 An adequate follow up period for outcome 
of interest 
* * * * * * * 
 Adequate follow up of cohorts * * * * * -- -- 
Overall quality score  
(Maximum score = 9/9) 
5/9 4/9 5/9 5/9 7/9 3/9 3/9 
a 
Each asterisk represents if an individual criterion within the subsection was fulfilled 
b All criteria receive a maximum score of “one star” except for comparability of study groups and an extra star may be allocated for the control 
of any additional confounding factors. 
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Figure 1  
Flow diagram of the process and results of study selection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Additional records identified 
through other sources  
(n = 0) 
Records identified through database 
searching  
(n = 2,941) 
Records after duplicates removed  
(n = 1,565) 
Records excluded  
(n = 56) 
Records screened  
(n = 81) 
Full-text articles excluded, 
with reasons  
(n = 14) 
Full-text articles assessed 
for eligibility  
(n = 25) 
Studies included in 
qualitative synthesis  
(n = 11) 
Figure1
Figure 2  
Risk of bias summary  
 
 
Entry with “Yes” (+) answers indicating a low risk of bias, “No” (-) answers indicating a 
high risk of bias, and “Unclear” (?) answers indicating an unknown risk of bias 
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